Brief: Tetra Bio-Pharma Announces Clinical Advancements And Establishment Of At-The-Market Equity Program

Tetra Bio Pharma

28/05/2021 12:24

May 28 (Reuters) - Tetra Bio Pharma Inc  TBP.TO :
    * TETRA BIO-PHARMA ANNOUNCES CLINICAL ADVANCEMENTS AND
ESTABLISHMENT OF AT-THE-MARKET EQUITY PROGRAM
    * TETRA BIO PHARMA INC - POSITIVE RESULTS OF FIRST STUDY IN
SARS-COV-2 INFECTED MICE.
    * TETRA BIO PHARMA INC - FIRST REBORN1© PATIENT ENTERS
CLINICAL
TRIAL.
    * TETRA BIO PHARMA INC - FILING OF IND FOR ARDS-003 ADAPTIVE
PHASE
1A/1B CLINICAL TRIAL.
    * TETRA BIO PHARMA INC - TO ISSUE UP TO $10 MILLION  OF
COMMON
SHARES

Source text for Eikon:  ID:nCNWr53dFa 
Further company coverage:  TBP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))